GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vifor Pharma AG (OTCPK:GNHAF) » Definitions » Net Margin %

Vifor Pharma AG (Vifor Pharma AG) Net Margin % : 2.07% (As of Dec. 2021)


View and export this data going back to 2013. Start your Free Trial

What is Vifor Pharma AG Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Vifor Pharma AG's Net Income for the six months ended in Dec. 2021 was $22 Mil. Vifor Pharma AG's Revenue for the six months ended in Dec. 2021 was $1,048 Mil. Therefore, Vifor Pharma AG's net margin for the quarter that ended in Dec. 2021 was 2.07%.

The historical rank and industry rank for Vifor Pharma AG's Net Margin % or its related term are showing as below:

GNHAF' s Net Margin % Range Over the Past 10 Years
Min: 7.74   Med: 9.02   Max: 88.8
Current: 7.96


GNHAF's Net Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 3.27 vs GNHAF: 7.96

Vifor Pharma AG Net Margin % Historical Data

The historical data trend for Vifor Pharma AG's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vifor Pharma AG Net Margin % Chart

Vifor Pharma AG Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 88.80 9.62 9.22 19.96 7.91

Vifor Pharma AG Semi-Annual Data
Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.57 8.02 30.52 14.48 2.07

Competitive Comparison of Vifor Pharma AG's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Vifor Pharma AG's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vifor Pharma AG's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vifor Pharma AG's Net Margin % distribution charts can be found below:

* The bar in red indicates where Vifor Pharma AG's Net Margin % falls into.



Vifor Pharma AG Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Vifor Pharma AG's Net Margin for the fiscal year that ended in Dec. 2021 is calculated as

Net Margin=Net Income (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=156.786/1981.107
=7.91 %

Vifor Pharma AG's Net Margin for the quarter that ended in Dec. 2021 is calculated as

Net Margin=Net Income (Q: Dec. 2021 )/Revenue (Q: Dec. 2021 )
=21.716/1048.1
=2.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vifor Pharma AG  (OTCPK:GNHAF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Vifor Pharma AG Net Margin % Related Terms

Thank you for viewing the detailed overview of Vifor Pharma AG's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Vifor Pharma AG (Vifor Pharma AG) Business Description

Traded in Other Exchanges
N/A
Address
Rechenstrasse 37, Saint Gallen, CHE, 9014
Vifor Pharma AG is a specialty drug manufacturing and licensing company. It researches, develops, and produces its pharmaceutical products and markets and distributes them worldwide. Most of its sales are generated in the USA, with Europe also a strong contributor. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Vifor Pharma AG (Vifor Pharma AG) Headlines